Airsculpt Technologies, Inc.
For the period ended Dec 31, 2024. Filed Mar 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 14, 2025
AIRS$0.77+14.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Twelve Months EndedDecember 31, | |||
|---|---|---|---|
| ($000s) | 2024 | 2023 | 2022 |
| Cash flows from operating activities | |||
| Net loss | $(8,251) | $(4,479) | $(14,679) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||
| Depreciation and amortization | 11,888 | 10,253 | 8,061 |
| Equity-based compensation | 3,762 | 18,224 | 29,457 |
| Non-cash interest expense; amortization of debt costs | 339 | 207 | 921 |
| Loss on debt modification | — | — | 932 |
| Deferred income taxes | (252) | 1,342 | 1,134 |
| Loss/(gain) on disposal of long-lived assets | 16 | (212) | 147 |
| Changes in assets and liabilities | |||
| Taxes receivable | (1,115) | 890 | (2,831) |
| Prepaid expense and other current assets | (2,059) | 466 | (5) |
| Other assets | (1,011) | (3,814) | (7,274) |
| Accounts payable | 739 | (206) | 865 |
| Deferred revenue and patient deposits | (293) | (896) | (452) |
| Accrued and other liabilities | 7,587 | 2,181 | 8,171 |
| Net cash provided by operating activities | 11,350 | 23,956 | 24,447 |
| Cash flows from investing activities | |||
| Purchases of property and equipment, net | (14,007) | (9,919) | (12,921) |
| Net cash used in investing activities | (14,007) | (9,919) | (12,921) |
| Cash flows from financing activities | |||
| Payment on term loan | (2,125) | (12,125) | (84,263) |
| Borrowings on term loan, net | — | — | 83,503 |
| Payments for debt modification | (136) | — | — |
| Proceeds from revolving credit facility | 5,000 | — | — |
| Distribution to member | — | (79) | (1,159) |
| Dividends paid to shareholders | (252) | (385) | (23,160) |
| Payment of taxes withheld through vested equity-based compensation | (903) | (233) | (2,031) |
| Other financing activity | (954) | (569) | (147) |
| Net cash provided by/(used in) financing activities | 630 | (13,391) | (27,257) |
| Net decrease in cash and cash equivalents | (2,027) | 646 | (15,731) |
| Cash and cash equivalents | |||
| Beginning of period | 10,262 | 9,616 | 25,347 |
| End of period | $8,235 | $10,262 | $9,616 |
| Supplemental disclosure of cash flow information: | |||
| Cash paid for interest | $5,997 | $6,277 | $5,830 |
| Cash paid for income taxes | $1,808 | $4,663 | $4,932 |
| Supplemental disclosure of non-cash investing information: | |||
| Property and equipment included in accounts payable and accrued expenses | $1,595 | $283 | $1,113 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.